aod9604: AOD9604 2mg Vial purity research formula manufactured in the USA AOD9604 | Research Grade |

(2008) Journal of Orthopaedic Research Rat model of articular cartilage defect treated with local and systemic AOD 9604 measuring cartilage repair and collagen synthesis

Its selective beta-3 adrenergic receptor-mediated lipolysis, combined with confirmed IGF-1 independence and absence of growth hormone receptor binding, makes it the most precise available molecular tool for studying fat metabolism pathways in isolation from the confounds associated with full-length hGH

No regulatory approval exists for AOD-9604 as an OA therapy in any jurisdiction

A systems-approach to NAD+ restoration

At its core is Semaglutide, a GLP-1 receptor agonist used as part of a comprehensive weight loss treatment plan